SURGERY VS BOTULINUM TOXIN ON QUALITY OF LIFE IN STROKE PATIENTS: RANDOMIZED TRIAL
NCT06392633 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 44
Last updated 2024-04-30
Summary
We present a research project in the form of a controlled clinical trial with the aim of analyzing and demonstrating whether the surgical treatment of upper limb spasticity is an effective and efficient measure to improve dependence and quality of life perceived by patients with sequelae of stroke and therefore, should be included in the therapeutic protocols, in which it is not usually contemplated, as a complement or alternative to traditional treatment with botulinum toxin, rehabilitation and occupational therapy.
Conditions
Interventions
- PROCEDURE
-
spastic hand sugery
Deformity correction can be performed with single event multilevel surgery, using a combination of soft tissue releases and lengthening, tendon transfers and joint stabilization procedures. In addition, selective and supraselective neurectomies can also be performed.
- DRUG
-
Botulinum Toxin A
Treatment consists of periodic injections of the toxin into the spastic muscles. It causes reversible chemical denervation by preventing the release of acetylcholine vesicles at the neuromuscular junctions of the affected muscles.
Sponsors & Collaborators
-
Fundación Pública Andaluza para la Investigación Biomédica Andalucía Oriental
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-01-01
- Primary Completion
- 2024-06-01
- Completion
- 2024-12-01
Countries
- Spain
Study Locations
More Related Trials
-
Long-term Efficacy of Spasticity-correcting Surgery and Botulinum Toxin Injections for Upper Limb Spasticity Treatment
NCT03910101 ·Status: COMPLETED ·Phase: NA
-
Evaluation of BOTOX® With Rehabilitation Therapy for the Treatment of Wrist and Hand Spasticity in Post-Stroke Patients
NCT00565201 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
A Prospective, Non-interventional Survey to Evaluate Injection Intervals and Treatment Modalities of Botulinum Toxin A (BoNT-A) in Adult Patients Suffering From Upper Limb Spasticity After Stroke
NCT01239628 ·Status: TERMINATED
-
A Study to Evaluate the Botulinum Toxin Type A for Injection(HengLi®) in Subjects With Post-stroke Upper Limb Spasticity
NCT02280083 ·Status: COMPLETED ·Phase: PHASE3
-
Comparative Study of the Effects of Dry Needling and Botulinum Toxin Type A as a Treatment for Lower Limb Post-stroke Spasticity
NCT06296082 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
Botulinum Toxin Type A and Modified Constraint-Induced Movement Therapy for Poststroke Upper Extremity Spasticity
NCT00723866 ·Status: COMPLETED ·Phase: NA
-
Study on the Use of Botulinum Toxin Type A in the Treatment of Chronic Post-stroke Spastic Patients
NCT02390206 ·Status: COMPLETED
-
Spastic Cocontractions and Limitation of Active Movements Before and After Treatment During Injection of Botulinum Toxin
NCT03453008 ·Status: UNKNOWN
-
Early Use of Botulinum Toxin in Spasticity Post Stroke.
NCT01882556 ·Status: COMPLETED ·Phase: PHASE2
-
Safety Study of Botulinum Toxin Type A in Post-Upper Limb Stroke Patients With Reduced Lung Function
NCT00076687 ·Status: COMPLETED ·Phase: PHASE2
-
Trial Comparing Two Commercial Formulations of Botulinum Toxin Type A in the Treatment of Spasticity
NCT00819065 ·Status: COMPLETED ·Phase: PHASE3
-
BOTOX® Versus Zanaflex® for the Treatment of Post-Stroke or Traumatic Brain Injury Upper Limb Spasticity
NCT00430196 ·Status: COMPLETED ·Phase: PHASE4
-
MEDITOXIN® Versus BOTOX® in the Treatment of Post-stroke Spasticity of the Upper Limb Spasticity
NCT01313767 ·Status: COMPLETED ·Phase: PHASE3
-
A Multicenter, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Safety of GSK1358820 (Botulinum Toxin Type A) in Chinese Subjects With Post-stroke Upper Limb Spasticity
NCT01153815 ·Status: COMPLETED ·Phase: PHASE3
-
Botulinum Toxin for Carpal Tunnel Syndrome
NCT00701233 ·Status: WITHDRAWN ·Phase: PHASE2
-
Early Treatment of Post-stroke Spasticity With Botulinum Toxin
NCT04404868 ·Status: COMPLETED
-
Randomized DB Controlled Trial of Botulinum Toxin A in Hemiplegic Shoulder Pain and Spasticity
NCT00661089 ·Status: COMPLETED ·Phase: NA
-
Effects of Botulinum Toxin Injections in Patients With Hereditary Spastic Paraplegia
NCT02604186 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
CORETOX® in Treatment of Post Stroke Upper Limb Spasticity (Phase1)
NCT05164003 ·Status: COMPLETED ·Phase: PHASE1
-
Early Botulinum Toxin for Muscle Stiffness Reduction in First-Time Stroke Patients: Improving Recovery and Independence
NCT06811142 ·Status: ACTIVE_NOT_RECRUITING ·Phase: EARLY_PHASE1
-
Central Effects of Botulinum Toxin: Neurophysiological Study in Stroke Patients With Spastic Lower Limb
NCT01829763 ·Status: UNKNOWN ·Phase: PHASE3
-
Study to Compare the Efficacy and Safety of NT 201 (Botulinum Toxin) With Placebo for the Treatment of Lower Limb Spasticity Caused by Stroke or Traumatic Brain Injury
NCT03992404 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Effectiveness of an Interprofessional Approach to the Treatment of Spasticity With Botulinum Toxin & Non-pharmacological Therapies
NCT07160699 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Upper Extremity Rehabilitation Using Robot and Botulinum Toxin
NCT02228863 ·Status: UNKNOWN ·Phase: PHASE4
-
BOTOX® (Onabotulinumtoxin A) Injection(s) as a Treatment for Carpal Tunnel Syndrome
NCT02070302 ·Status: COMPLETED ·Phase: PHASE2